World's Best Scientists 2026 revealed!
Walter E. Haefeli

Walter E. Haefeli

D-Index & Metrics

Medicine

D-Index
88
Citations
26645
World Ranking
13225
National Ranking
705

Walter E. Haefeli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Walter E. Haefeli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 645 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Walter E. Haefeli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Walter E. Haefeli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Walter E. Haefeli is affiliated with Heidelberg University in Germany and has a substantial body of work primarily in the field of Medicine. Their research encompasses several key subfields including Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Pharmacology, Oncology, and Molecular Biology.

The main topics of Haefeli's work cover various aspects of pharmaceutical sciences and patient care. These topics include:

  • Pharmaceutical Practices and Patient Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Drug Transport and Resistance Mechanisms
  • Pharmacogenetics and Drug Metabolism
  • Pharmaceutical studies and practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac electrophysiology and arrhythmias

Haefeli has published extensively in several notable venues. The frequent publication venues include:

  • Pharmaceutics
  • Clinical Pharmacokinetics
  • European Journal of Clinical Pharmacology
  • Research in Social and Administrative Pharmacy
  • International Journal of Molecular Sciences

Among recent papers authored or co-authored by Haefeli are the following:

  • IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression, 2020, Cell
  • Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial, 2022, The Lancet Infectious Diseases
  • Drug-Drug Interactions with Direct Oral Anticoagulants, 2020, Clinical Pharmacokinetics
  • A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy, 2020, Leukemia
  • A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial, 2023, Alzheimer s & Dementia

Haefeli collaborates frequently with several co-authors, including:

  • Jürgen Burhenne
  • Hanna M. Seidling
  • Andreas D. Meid
  • Kathrin I. Foerster
  • Johanna Weiß

Best Publications

  • Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo

    Robinson Joannides;Walter E. Haefeli;Lilly Linder;Vincent Richard

  • IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

    Ahmed Sadik;Luis F Somarribas Patterson;Selcen Öztürk;Soumya R Mohapatra

  • Prolonged sedation due to accumulation of conjugated metabolites of midazolam

    T.M. Bauer;R. Ritz;C. Haberthür;W.E. Haefeli

  • Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

    Pavel Bogomolov;Alexander Alexandrov;Natalia Voronkova;Maria Macievich

  • Inhibition of P-Glycoprotein by Newer Antidepressants

    Johanna Weiss;Sven-Maria Gregor Dormann;Meret Martin-Facklam;Christian Johannes Kerpen

  • Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver

    Nadine Albermann;Friedrich Hubertus Schmitz-Winnenthal;Kaspar Z’graggen;Christine Volk

  • Associations of frailty with health care costs – results of the ESTHER cohort study

    Jens Oliver Bock;Hans Helmut König;Hermann Brenner;Hermann Brenner;Walter E. Haefeli

  • Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms

    Julia T. Schiele;Renate Quinzler;Hans-Dieter Klimm;Markus G. Pruszydlo

  • Modulation of human BCRP (ABCG2) activity by anti-HIV drugs

    Johanna Weiss;Johanna Rose;Caroline Henrike Storch;Nahal Ketabi-Kiyanvash

  • CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.

    Johanna Weiss;Magdalena Maria ten Hoevel;Jürgen Burhenne;Ingeborg Walter-Sack

  • Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.

    Ina Scholz;Heike Oberwittler;Klaus-Dieter Riedel;Jürgen Burhenne

  • First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B

    Antje Blank;Christoph Markert;Nicolas Hohmann;Alexandra Carls

  • Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

    Reinhard Ding;Yorki Tayrouz;Klaus‐Dieter Riedel;Jürgen Burhenne

  • Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein

    Caroline Henrike Storch;Dirk Theile;Heike Lindenmaier;Walter Emil Haefeli

  • Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study

    Kai Uwe Saum;Ben Schöttker;Ben Schöttker;Andreas D. Meid;Bernd Holleczek

  • Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

    Gerd Mikus;Verena Schöwel;Magdalena Drzewinska;Jens Rengelshausen

  • Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany.

    Cornelia Mahler;Katja Hermann;Rob Horne;Sabine Ludt

  • Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.

    Jens Rengelshausen;Maria Banfield;Klaus‐Dieter Riedel;Jürgen Burhenne

  • Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.

    Johanna Weiss;Dirk Theile;Nahal Ketabi-Kiyanvash;Heike Lindenmaier

  • Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema.

    Marc M. Berger;Christiane Hesse;Christoph Dehnert;Heike Siedler

Frequent Co-Authors

Hermann Brenner
Hermann Brenner German Cancer Research Center
Hans-Helmut König
Hans-Helmut König Universität Hamburg
Ben Schöttker
Ben Schöttker Heidelberg University
Herbert Matschinger
Herbert Matschinger Leipzig University
Stephan Rosenkranz
Stephan Rosenkranz University of Cologne
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Christel Herold-Mende
Christel Herold-Mende Heidelberg University
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Marjan van den Akker
Marjan van den Akker Goethe University Frankfurt
Stephan Urban
Stephan Urban University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open up diverse pathways for those interested in healthcare and medicine. Many students begin with programs connected to nutrition or allied health, such as earning the best online food science degree—an option for those passionate about health promotion and disease prevention through diet.

For those seeking leadership roles or management positions, pursuing accredited mha programs online enables advancement into hospital and healthcare administration. Nurses looking to further their credentials may consider bridge programs, such as an online rn to bsn no clinicals program, offering flexible coursework for working professionals.

Advanced practice nurses aiming for the highest clinical roles can enroll in the shortest msn to dnp program, accelerating their journey toward a Doctor of Nursing Practice. Each of these pathways supports varied interests—whether it’s science, direct patient care, or healthcare management—helping you tailor your career path in today’s evolving medical field.

Best Scientists Citing Walter E. Haefeli

Trending Scientists

Recently Published Articles